规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
100mg | ¥ ȖǫēĊĊ | > 10 | -- | -- | -- | 1 | -- | ¥ ȖǫēĊĊ | - + |
50mg | ¥ ŹĞēĊĊ | > 10 | -- | -- | -- | -- | -- | ¥ ŹĞēĊĊ | - + |
1g | ¥ ƳǫȖēĊĊ | > 10 | -- | -- | -- | -- | -- | ¥ ƳǫȖēĊĊ | - + |
5g | ¥ ǫƳŹƳēĊĊ | > 10 | -- | -- | -- | 1 | -- | ¥ ǫƳŹƳēĊĊ | - + |
10g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
5g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
100g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
110.6
[1]. Beumer JH, et, al. Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro- -deoxycytidine in mice. Clin Cancer Res. 006 Dec 15;1(4):48-91.
[]. Osterman DG, et, al. 5-Fluorocytosine in DNA is a mechanism-based inhibitor of HhaI methylase. Biochemistry. 1988 Jul 1;(14):504-10.
[]. D J Baker, et al. Transition state analogs as affinity labels for human DNA methyltransferases. Biochem Biophys Res Commun. 199 Oct 9;196():864-1.
[4]. Duoli Guo, et al. Stability of 5-fluoro- -deoxycytidine and tetrahydrouridine in combination. AAPS PharmSciTech. 010 Mar;11(1):4-5.
[5]. H Stopper, et al. Micronuclei induced by modulators of methylation: analogs of 5-azacytidine. Carcinogenesis. 1995 Jul;16():164-50.
H0-H15-H19-H-H5
P61-P64-P0-P1-P80-P0+P5-P04+P40-P0-P6+P64-P405-P501
GHS0